A critical feature of the dementia of the Alzheimer type is an interference with the formation of both short-and long term memory. One clue that has emerged from a family of recent studies is that the hippocampus is involved in human memory and that damage to only the CA, region is sufficient to impair the normal conversion of short- to long- term memory. Since LTP occurs in the CA, region, it now becomes possible to begin to explore in cellular and molecular terms several elementary questions pertaining to normal memory storage. Over the last several years, we have been exploring the mechanisms underlying short- and long term memory in a simple invertebrate system, the monosynaptic component of the gill- and siphon-withdrawal reflex in Aplysia. Specifically, we found that the proteins synthesized for long-term memory are utilized for two distinct molecular mechanisms; 1) A transcriptionally dependent persistence in the phosphorylation of the same substrate proteins phosphorylated in the short- term. This results from transcriptionally- dependent depression, perhaps by proteolytic cleavage of the level of the regulatory subunit of the cAMP-dependent kinase, with the result that the catalytic subunit becomes constitutively active, in the absence of an elevated level of cyclic AMP. This persistence in kinase activity gives the long-term process its striking resemblance to the short term process. 2) The activation of a growth process whereby new synaptic terminals are formed. This growth process is correlated with, and perhaps results from, the activation of a set of proteins that bear resemblance to the immediate early proteins activated in mammalian cells in response to growth factors. The program outline in this proposal attempts to extend to the mammalian brain, and specifically to hippocampal LTP in the CA, region, the approach we have developed in our work on Aplysia. We now plan to explore in the hippocampus six interrelated questions: 10 What is the pattern of phosphorylation produced by LTP? How does the pattern established during the maintenance phase of LTP (2-3 hrs), compare to that of the induction phase (30-60 min)? 2) How does the pattern of phosphorylation, mediated by the C kinase, the Ca2+/calmodulin-dependent kinase or other known second messenger kinases compare to the pattern during initiation of LTP? 3) Does the maintenance of LTP involve persistent phosphorylation by one of these kinases? 4) Is this phosphorylation in the maintenance phase inducted by second messengers, transcriptionally dependent? 5) Does LTP depend on the synthesis of new proteins and mRNAs? 6) If so, what are the genes and proteins whose expression is changed following LTP?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-09
Application #
6234219
Study Section
Project Start
1997-06-15
Project End
1998-05-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 640 publications